These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

111 related items for PubMed ID: 15665745

  • 1. A sensitive HPLC method for the determination of fluoxetine and norfluoxetine in human plasma with fluorescence detection.
    Ertürk S, Cetin SM, Atmaca S, Ersoy L, Baktr G.
    Ther Drug Monit; 2005 Feb; 27(1):38-43. PubMed ID: 15665745
    [Abstract] [Full Text] [Related]

  • 2. Three-phase, liquid-phase microextraction combined with high performance liquid chromatography-fluorescence detection for the simultaneous determination of fluoxetine and norfluoxetine in human plasma.
    de Freitas DF, Porto CE, Vieira EP, de Siqueira ME.
    J Pharm Biomed Anal; 2010 Jan 05; 51(1):170-7. PubMed ID: 19683889
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. A simple method to monitor serum concentrations of fluoxetine and its major metabolite for pharmacokinetic studies.
    Franceschi L, Faggiani A, Furlanut M.
    J Pharm Biomed Anal; 2009 Feb 20; 49(2):554-7. PubMed ID: 19117710
    [Abstract] [Full Text] [Related]

  • 5. Simultaneous determination of plasma levels of fluvoxamine and of the enantiomers of fluoxetine and norfluoxetine by gas chromatography-mass spectrometry.
    Eap CB, Gaillard N, Powell K, Baumann P.
    J Chromatogr B Biomed Appl; 1996 Jul 12; 682(2):265-72. PubMed ID: 8844419
    [Abstract] [Full Text] [Related]

  • 6. Liquid chromatographic-mass spectrometric method for the determination of fluoxetine and norfluoxetine in human plasma: application to clinical study.
    Djordjevic S, Kovacevic I, Miljkovic B, Vuksanovic J, Pokrajac M.
    Farmaco; 2005 Apr 12; 60(4):345-9. PubMed ID: 15848211
    [Abstract] [Full Text] [Related]

  • 7. Sensitive and selective liquid-chromatographic assay of fluoxetine and norfluoxetine in plasma with fluorescence detection after precolumn derivatization.
    Suckow RF, Zhang MF, Cooper TB.
    Clin Chem; 1992 Sep 12; 38(9):1756-61. PubMed ID: 1526010
    [Abstract] [Full Text] [Related]

  • 8. Liquid chromatography/tandem mass spectrometry for the determination of fluoxetine and its main active metabolite norfluoxetine in human plasma with deuterated fluoxetine as internal standard.
    Li C, Ji Z, Nan F, Shao Q, Liu P, Dai J, Zhen J, Yuan H, Xu F, Cui J, Huang B, Zhang M, Yu C.
    Rapid Commun Mass Spectrom; 2002 Sep 12; 16(19):1844-50. PubMed ID: 12271449
    [Abstract] [Full Text] [Related]

  • 9. Determination of fluoxetine and norfluoxetine in human plasma by high-pressure liquid chromatography with fluorescence detection.
    Raggi MA, Mandrioli R, Casamenti G, Bugamelli F, Volterra V.
    J Pharm Biomed Anal; 1998 Oct 12; 18(1-2):193-9. PubMed ID: 9863958
    [Abstract] [Full Text] [Related]

  • 10. Determination of the antidepressant fluoxetine and its metabolite norfluoxetine in serum by reversed-phase HPLC with ultraviolet detection.
    Orsulak PJ, Kenney JT, Debus JR, Crowley G, Wittman PD.
    Clin Chem; 1988 Sep 12; 34(9):1875-8. PubMed ID: 3262022
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Simultaneous analysis of olanzapine, fluoxetine, and norfluoxetine in human plasma using liquid chromatography-mass spectrometry and its application to a pharmacokinetic study.
    Ni XJ, Wang ZZ, Shang DW, Lu HY, Zhang M, Wen YG.
    J Chromatogr B Analyt Technol Biomed Life Sci; 2018 Aug 15; 1092():506-514. PubMed ID: 30008307
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Sensitive, high-throughput gas chromatographic-mass spectrometric assay for fluoxetine and norfluoxetine in human plasma and its application to pharmacokinetic studies.
    Addison RS, Franklin ME, Hooper WD.
    J Chromatogr B Biomed Sci Appl; 1998 Sep 25; 716(1-2):153-60. PubMed ID: 9824228
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Determination of fluoxetine, norfluoxetine and their enantiomers in rat plasma and brain samples by liquid chromatography with fluorescence detection.
    Unceta N, Barrondo S, Ruiz de Azúa I, Gómez-Caballero A, Goicolea MA, Sallés J, Barrio RJ.
    J Chromatogr B Analyt Technol Biomed Life Sci; 2007 Jun 01; 852(1-2):519-28. PubMed ID: 17329174
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.